Glucose metabolism in RIF-1 tumors after reduction in blood flow: An in vivo 13C and 31P NMR study

Zaver M Bhujwalla, D. C. Shungu, J. C. Chatham, J. P. Wehrle, J. D. Glickson

Research output: Contribution to journalArticle

Abstract

Low pH appears to enhance the effectiveness of therapeutic hyperthermia. 13C and 31P NMR spectroscopy have been employed to examine the possibility that elevating glucose in a solid tumor while simultaneously reducing tumor blood flow would induce a more profound acidosis than either treatment alone. When blood flow in RIF-1 tumors was acutely reduced by administration of hydralazine and additional glucose was delivered locally by intratumoral injection, tumor acidosis (as determined by 31P NMR spectroscopy) during the period of reduced blood flow was not enhanced, relative to administration of hydralazine alone. Tumor NTP/P(i) ratios decreased significantly within 20 min of hydralazine administration, whether or not glucose was injected, although NTP/P(i) ratios were slightly higher in tumors that received extra glucose. Tumor lactate concentrations were not significantly different in glucose-supplemented tumors, despite glucose concentrations that were 4 to 5 times higher. When the added glucose was labeled with 13C, no correlation was detected between the pH in an individual tumor and the intensity of the 3-[13C]-lactate resonance in the same tumor.

Original languageEnglish (US)
Pages (from-to)303-309
Number of pages7
JournalMagnetic Resonance in Medicine
Volume32
Issue number3
StatePublished - 1994

Fingerprint

Glucose
Neoplasms
Hydralazine
Acidosis
Lactic Acid
Magnetic Resonance Spectroscopy
Carbon-13 Magnetic Resonance Spectroscopy
Induced Hyperthermia
Injections

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Glucose metabolism in RIF-1 tumors after reduction in blood flow : An in vivo 13C and 31P NMR study. / Bhujwalla, Zaver M; Shungu, D. C.; Chatham, J. C.; Wehrle, J. P.; Glickson, J. D.

In: Magnetic Resonance in Medicine, Vol. 32, No. 3, 1994, p. 303-309.

Research output: Contribution to journalArticle

Bhujwalla, Zaver M ; Shungu, D. C. ; Chatham, J. C. ; Wehrle, J. P. ; Glickson, J. D. / Glucose metabolism in RIF-1 tumors after reduction in blood flow : An in vivo 13C and 31P NMR study. In: Magnetic Resonance in Medicine. 1994 ; Vol. 32, No. 3. pp. 303-309.
@article{f3346b02a3bf41d69c788e07ad51dfea,
title = "Glucose metabolism in RIF-1 tumors after reduction in blood flow: An in vivo 13C and 31P NMR study",
abstract = "Low pH appears to enhance the effectiveness of therapeutic hyperthermia. 13C and 31P NMR spectroscopy have been employed to examine the possibility that elevating glucose in a solid tumor while simultaneously reducing tumor blood flow would induce a more profound acidosis than either treatment alone. When blood flow in RIF-1 tumors was acutely reduced by administration of hydralazine and additional glucose was delivered locally by intratumoral injection, tumor acidosis (as determined by 31P NMR spectroscopy) during the period of reduced blood flow was not enhanced, relative to administration of hydralazine alone. Tumor NTP/P(i) ratios decreased significantly within 20 min of hydralazine administration, whether or not glucose was injected, although NTP/P(i) ratios were slightly higher in tumors that received extra glucose. Tumor lactate concentrations were not significantly different in glucose-supplemented tumors, despite glucose concentrations that were 4 to 5 times higher. When the added glucose was labeled with 13C, no correlation was detected between the pH in an individual tumor and the intensity of the 3-[13C]-lactate resonance in the same tumor.",
author = "Bhujwalla, {Zaver M} and Shungu, {D. C.} and Chatham, {J. C.} and Wehrle, {J. P.} and Glickson, {J. D.}",
year = "1994",
language = "English (US)",
volume = "32",
pages = "303--309",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Glucose metabolism in RIF-1 tumors after reduction in blood flow

T2 - An in vivo 13C and 31P NMR study

AU - Bhujwalla, Zaver M

AU - Shungu, D. C.

AU - Chatham, J. C.

AU - Wehrle, J. P.

AU - Glickson, J. D.

PY - 1994

Y1 - 1994

N2 - Low pH appears to enhance the effectiveness of therapeutic hyperthermia. 13C and 31P NMR spectroscopy have been employed to examine the possibility that elevating glucose in a solid tumor while simultaneously reducing tumor blood flow would induce a more profound acidosis than either treatment alone. When blood flow in RIF-1 tumors was acutely reduced by administration of hydralazine and additional glucose was delivered locally by intratumoral injection, tumor acidosis (as determined by 31P NMR spectroscopy) during the period of reduced blood flow was not enhanced, relative to administration of hydralazine alone. Tumor NTP/P(i) ratios decreased significantly within 20 min of hydralazine administration, whether or not glucose was injected, although NTP/P(i) ratios were slightly higher in tumors that received extra glucose. Tumor lactate concentrations were not significantly different in glucose-supplemented tumors, despite glucose concentrations that were 4 to 5 times higher. When the added glucose was labeled with 13C, no correlation was detected between the pH in an individual tumor and the intensity of the 3-[13C]-lactate resonance in the same tumor.

AB - Low pH appears to enhance the effectiveness of therapeutic hyperthermia. 13C and 31P NMR spectroscopy have been employed to examine the possibility that elevating glucose in a solid tumor while simultaneously reducing tumor blood flow would induce a more profound acidosis than either treatment alone. When blood flow in RIF-1 tumors was acutely reduced by administration of hydralazine and additional glucose was delivered locally by intratumoral injection, tumor acidosis (as determined by 31P NMR spectroscopy) during the period of reduced blood flow was not enhanced, relative to administration of hydralazine alone. Tumor NTP/P(i) ratios decreased significantly within 20 min of hydralazine administration, whether or not glucose was injected, although NTP/P(i) ratios were slightly higher in tumors that received extra glucose. Tumor lactate concentrations were not significantly different in glucose-supplemented tumors, despite glucose concentrations that were 4 to 5 times higher. When the added glucose was labeled with 13C, no correlation was detected between the pH in an individual tumor and the intensity of the 3-[13C]-lactate resonance in the same tumor.

UR - http://www.scopus.com/inward/record.url?scp=0028106360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028106360&partnerID=8YFLogxK

M3 - Article

C2 - 7984062

AN - SCOPUS:0028106360

VL - 32

SP - 303

EP - 309

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 3

ER -